FDA Grants Approval for Brimonidine Tartrate and Timolol Maleate ANDA219166
The FDA has granted approval for ANDA219166, a generic formulation containing Brimonidine Tartrate and Timolol Maleate.
Asset / Drug
Drug and asset intelligence for GLAND with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.